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Polyacrylamide as a biocompetible polymeric material can be used in modifying drug release of aspirin. But limitations in absorbing water on 
this  polymer can be covered with the addition of carboxymethyl amylose which is having more hydrophilic properties and may assist in 
crosslinking. The incorporation of carboxymethyl amylose and polyacrylamide were carried out by grafting methods and used polymerized 
with solution method. The results of the synthesis of carboxymethyl amylose-g-polyacrylamide are expected to have a more controlled 
release of aspirin which may minimize the side effect of delivery. The results of the synthesis of CMA-g-PAM and its formation were  
characterized by FTIR, XRD, swelling degrees (DS), and percent grafting efficiency (% GE). CMA-g-PAM products are expected to have more 
hydrophifilic and more biodegradable properties. The research show that CMA-g-PAM was succesfully synthesize by this method. The 
evident can be seen in XRD analysis from peak and graph observation. With the value of %GE found on the CMA-g-PAM DS 3 can reach up to 
98.14% with concentration of  NaOH 1.5 M, and a reasonable degree of swelling presented in the concentration of 2.5 M NaOH is 5699.52. 
 




Aspirin can cause injury to the gastrointestinal tract by chelation of divalent metals and/or cations in the 
mucus ultivalen gastrointenstinal and mucosa, as a result of the chemical properties [1]. Shargel and Yu [2] 
reported oral administration of aspirin tablets cause bleeding in the stomach. Therefore, aspirin should be coated 
with polymer to protect the stomach, so it will not be harmful and safe to consume. 
The Ability to absorb water (swelling) in Polyacrylamide is limited. To improve the hydrophilic properties, 
grafting process is carried out with a hydrophilic polymer like amylose, which is perfectly soluble in water by 
heating at a maximum temperature of 60°C. Grafting to is used in this method because it can produce a high 
success rate of synthesis. In this research we used amylose derivative namely carboxymethyl amylose. These 
derivatives compounds have more hydrophilic properties than amylose. Variable to study is the variation of NaOH 
concentration in the synthesis of carboxymethyl amylose (CMA). Grafting process is expected to increase the 
solubility of polyacrylamide. 
The current study focuses on controlled drug release system of aspirin. Process Polymerization is initiated by 
grafting to the carboxymethyl amylose by polyacrylamide. Grafting the polymer as well as polymer synthesis CMA 
at various concentrations of NaOH is expected to reduce the side effects of aspirin in the body. These results can 
be seen from the drug release aspirin test by using phosphate buffer as simulated in the gut. Beside other 
properties of the polymers are expected to remain held as a biocompatible, non-toxic and biodegradable. 
 
2. Materials and Methods 
2. 1  The materials used 
Aspirin powder, NaOH solution, TEMED, K2S2O8, and chloroacetic acid. 
2. 2  Variable of the research 
Independent variables: the composition of NaOH; 0.5 M, 1.0 M, 1.5 M, 2.0 M; 2.5 M in the synthesis of 
Carboxymethyl amylose 
Dependent variable : the composition of aspirin (80mg) 
Response variables : drug release of aspirin 
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2. Condensor Liebieg 
3. Indicator temperature  
4. Waterbath 
5. Three Pumpkin Neck 
6. N2 gas 
 
2. 4  The methods used 
Synthesis CMA-g-PAM 
Grafting method is used grafting to. This synthesis begins with the Synthesis of carboxymethyl amylose (CMA) 
and non-terminated polyacrylamide (nt-PAM). Then the process of grafting is between the CMA and the   nt-PAM 
and the result is called CMA-g-PAM. The procedures for synthesis of CMA-g-PAM are as follows. 
1. A total of 2.5 g NaOH concentration variation of CMA with a predetermined dissolved in 100 mL of 
distilled water in a stirred reactor and heated to a temperature of 60 ° C. Then cooled to room 
temperature. In the next phase, a mixture of nitrogen gas flows for 20 minutes. 
2. Non-termination of polyacrylamide has been synthesized, inserted into a reactor containing solution of 
CMA. 
3. Coupling reactions are performed in the reactor at a temperature of 50 ° C for 60 minutes. 
4. The result of the polymer is placed in 1000 mL beaker glass. Then it is precipitated with acetone for 6 
hours. The resulting product is called hydrogel. The homopolymer and the rest of the CMA that did not 
undergo the grafting remains in the filtrate. 
5. Product formed gel is dried in an oven to dry.  
 
Measurement of Degree of Swelling 
The degree of swelling measurements performed to determine the ease of polymer dissolved in a solvent. 
1. A total of 0.5 g of CMA-g-PAM was dissolved in 25 mL distilled water. 
2. The degree of swelling measurements carried out at intervals of 2, 5, 10, 20, 60, and 120 minutes. 
Measurement of the degree of swelling using the following equation. 
 
       [1] 
 
Where B1 and B0 in a row are a heavy substance that has experienced severe swelling and early substance 
[3] 
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Determination of the percentage of drug release  
1. Measurements performed on the drug release in simulated gastric (gastinal fluid) and intestines 
(intestinal fluid). Measurement of drug release (DR) is done by using a spectrophotometric method. This 
method begins with the establishment of buffer solution. 
2. Aspirin is inserted into the mixture of acid buffer (pH 1.2) and alkaline buffer (7.4) up to 900 mL [4] 
3. The data absorbance measurements made at each interval on aspirin dissolution method of adjusting 
according to FDA, 2011 with modifications.  
4. Subsequent measurement of each polymer is mixed with aspirin. Measurement steps starting from step 2. 




Where Cn = concentration after correction, C'n = concentration and Cs is the concentration read before. 




  Cn = concentration corrected, and Ct = Concentration of the theoretical 
 
 
3. Results and Discussion 
Carboxymethyl amylose grafted polyacrylamide (CMA-g-PAM) has been synthesized by grafting a nt-PAM on 
carboxymethyl amylose as the backbone. In the early stage of synthesized amylose, carboxymethyl amylose is 
reacted with a variation of the concentration of NaOH. The addition of NaOH is intended to augment the 
formation of carboxymethyl amylose. In the next phase, the synthesis of non-terminated polyacrylamide (nt-PAM) 
of acrylamide, without any termination process, is combined with the non-terminated polyacrylamide (nt-PAM) on 
carboxymethyl amylose’s backbone using the grafting to. The results obtained are CMA-g-PAM, which is then 
characterized on the degree of swelling as well as the performance of the drug release aspirin. 
3.1. Swelling Results Analysis  
The degree of swelling measurements carried out under acidic conditions (pH 1.2) and alkaline (pH7.4).  The 
use of pH 1.2 and 7.4 of this suit the conditions of the body. At pH 1.2 is a simulation system in the acidic stomach. 
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Figure 3. Results of swelling analysis CMA-g-PAM at pH 7,4 
 




 [5]. At pH 
1.2 CMA-g-PAM polymer chains only stretch when the aspirin still covered in the composites polymer. Meanwhile, 
at pH 7.4, it shows that the degree of swelling of CMA-g-PAM is greater than at pH 1.2. At pH 7.4, hydrogel CMA-g-
PAM undergoes a process of erosion that makes the aspirin released in the intestine where the aspirin is being 
absorbed, so the expected therapeutic effect can be achieved.  
 
3.2. Drug Release Results Analysis 
Figure 4 shows that the composite of CMA-g-PAM protect the stomach from aspirin because it has a lower 
value on drug release than  the aspirin has. Whereas at pH 7.4 composite of CMA-g-PAM can effective release the 
aspirin. It can be seen from the value of aspirin drug release that is under the composite of CMA-g-PAM. This can 
be attributed to the degree of swelling. In the state of the stomach only occurs stretching the polymer alone, 
which resulted in the release of aspirin to be low. At pH 7.4-g-PAM CMA undergoes a process of erosion that 
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Figure 5. Drug release profile of CMA-g-PAM at pH 7,4 
 
4.   Conclusion 
Based on the research have been executed can be concluded that: 
1. The value of the degree of swelling Increasing with increasing time. Where the greatest swelling at pH 7.4 
2. CMA-g-PAM is proven to withstand the rate of release of aspirin in the stomach (pH 1.2) 
3. CMA-g-PAM is proven to remove the aspirin of the intestine (pH 7.4) 
4. CMA-g-PAM proved effective for targeted drug peleasan in the gut. 
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